Boryung Pharmaceutical Co Ltd (003850):企業の財務・戦略的SWOT分析

◆英語タイトル:Boryung Pharmaceutical Co Ltd (003850) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15131
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boryung Pharmaceutical Co Ltd (Boryung), formerly Boryung Drugs Co Ltd is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE). The company provides major products such as Kanarb, a new drug for the treatment of hypertension; and Gelfos, an antacid for the treatment of hypergastric acidity, gastritis and gastric fullness, among others. It also provides cardiovascular products, antibiotics, amino acids and cosmetics, active pharmaceutical ingredients (APIs), and others. Boryung has pipeline products for the treatment of cardiovascular conditions, metabolism and fungal infections. The company’s products include diabetes, dyslipidemia and chronic kidney disease, besides hormones, and others. Boryung is headquartered in Seoul, South Korea.

Boryung Pharmaceutical Co Ltd Key Recent Developments

Jul 09,2018: Local drug makers strive to conquer neurological diseases

This comprehensive SWOT profile of Boryung Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Boryung Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Boryung Pharmaceutical Co Ltd – Key Information
Boryung Pharmaceutical Co Ltd – Overview
Boryung Pharmaceutical Co Ltd – Key Employees
Boryung Pharmaceutical Co Ltd – Key Employee Biographies
Boryung Pharmaceutical Co Ltd – Key Operational Heads
Boryung Pharmaceutical Co Ltd – Major Products and Services
Boryung Pharmaceutical Co Ltd – History
Boryung Pharmaceutical Co Ltd – Company Statement
Boryung Pharmaceutical Co Ltd – Locations And Subsidiaries
Boryung Pharmaceutical Co Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Boryung Pharmaceutical Co Ltd – Business Description
Boryung Pharmaceutical Co Ltd – Corporate Strategy
Boryung Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Boryung Pharmaceutical Co Ltd – Strengths
Boryung Pharmaceutical Co Ltd – Weaknesses
Boryung Pharmaceutical Co Ltd – Opportunities
Boryung Pharmaceutical Co Ltd – Threats
Boryung Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Boryung Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Boryung Pharmaceutical Co Ltd, Key Information
Boryung Pharmaceutical Co Ltd, Key Ratios
Boryung Pharmaceutical Co Ltd, Share Data
Boryung Pharmaceutical Co Ltd, Major Products and Services
Boryung Pharmaceutical Co Ltd, History
Boryung Pharmaceutical Co Ltd, Key Employees
Boryung Pharmaceutical Co Ltd, Key Employee Biographies
Boryung Pharmaceutical Co Ltd, Key Operational Heads
Boryung Pharmaceutical Co Ltd, Other Locations
Boryung Pharmaceutical Co Ltd, Subsidiaries
Boryung Pharmaceutical Co Ltd, Key Manufacturing facilities
Boryung Pharmaceutical Co Ltd, Key Competitors
Boryung Pharmaceutical Co Ltd, SWOT Analysis
Boryung Pharmaceutical Co Ltd, Ratios based on current share price
Boryung Pharmaceutical Co Ltd, Annual Ratios
Boryung Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Boryung Pharmaceutical Co Ltd, Performance Chart
Boryung Pharmaceutical Co Ltd, Ratio Charts

★海外企業調査レポート[Boryung Pharmaceutical Co Ltd (003850):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratory Corporation of America Holdings:企業のM&A・事業提携・投資動向
    Laboratory Corporation of America Holdings - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laboratory Corporation of America Holdings Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Daigas Group:企業の戦略・SWOT・財務分析
    Daigas Group - Strategy, SWOT and Corporate Finance Report Summary Daigas Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MGM Resorts International:企業のM&A・事業提携・投資動向
    MGM Resorts International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MGM Resorts International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Singapore Exchange Limited (S68):企業の財務・戦略的SWOT分析
    Singapore Exchange Limited (S68) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eleison Pharmaceuticals LLC (Eleison Pharmaceuticals) is a drug development company that acquires, develops, and commercializes clinical stage drug candidates for orphan cancers. The company’s pipeline products include glufosfamide and inhaled lipid-complexed cisplatin. Its glufosfamide is a …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Samba Private Banking:企業の戦略・SWOT・財務分析
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Camel-IDS NV:製薬・医療:M&Aディール及び事業提携情報
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company that develops radio-immunotherapeutic drugs for cancer patients. The company offers developing of compound radiopharmaceutical drugs for treatment of Her2 positive cancer. Its technology platform is based on recombinant, small antigen-bindi …
  • BRS Aerospace:企業の戦略・SWOT・財務情報
    BRS Aerospace - Strategy, SWOT and Corporate Finance Report Summary BRS Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Specialist Computer Centres Plc:企業の戦略・SWOT・財務情報
    Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report Summary Specialist Computer Centres Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Capital Lease Aviation Limited
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • EnergyAustralia Pty Ltd-エネルギー分野:企業M&A・提携分析
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, and wind sources. EnergyAustralia offers home …
  • Microbot Medical Inc (MBOT):企業の財務・戦略的SWOT分析
    Summary Microbot Medical Inc (Microbot), formerly StemCells Inc, is a pre-clinical medical device company that researches, designs and develops micro-robotics assisted medical technologies for minimally invasive surgeries. The company’s product candidates include Self Cleaning Shunt, intended for th …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Savior Lifetec Corp (4167):製薬・医療:M&Aディール及び事業提携情報
    Summary Savior Lifetec Corp (SLC) is an injectable manufacturer and distributor. The company offers active pharmaceutical ingredients (APIs) and finished dosage formulations. It provides sterile crystallization and aseptic processing of sterile powder. SLC offers carbapenem products, which include i …
  • Moss Bros Group Plc:企業の戦略的SWOT分析
    Moss Bros Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Driver and Vehicle Standards Agency:企業の戦略的SWOT分析
    Driver and Vehicle Standards Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆